154 related articles for article (PubMed ID: 19272503)
21. Intravesical migration of levonorgestrel-releasing intrauterine system (LNG-IUS) with calculus formation.
Khan ZA; Khan SA; Williams A; Mobb GE
Eur J Contracept Reprod Health Care; 2006 Sep; 11(3):243-5. PubMed ID: 17056458
[TBL] [Abstract][Full Text] [Related]
22. Is there a role for use of levonorgestrel intrauterine system in women with chronic pelvic pain?
Anpalagan A; Condous G
J Minim Invasive Gynecol; 2008; 15(6):663-6. PubMed ID: 18774757
[TBL] [Abstract][Full Text] [Related]
23. Endometrial vascularization in levonorgestrel intrauterine device users; computerized microvessel measurement study.
Jondet M; Letellier B; Verdys MT
Contraception; 2005 Jan; 71(1):60-4. PubMed ID: 15639075
[TBL] [Abstract][Full Text] [Related]
24. Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study.
Ng YW; Liang S; Singh K
Contraception; 2009 Jan; 79(1):24-8. PubMed ID: 19041437
[TBL] [Abstract][Full Text] [Related]
25. Progestin-releasing intrauterine systems and leiomyoma.
Kaunitz AM
Contraception; 2007 Jun; 75(6 Suppl):S130-3. PubMed ID: 17531604
[TBL] [Abstract][Full Text] [Related]
26. Contraceptive and noncontraceptive benefits of the LNG-IUS in a vertically integrated HMO.
Hendlish SK; Horowicz-Mehler NC; Brixner DI; Stern LS; Doyle JJ; Chang J; Hagan M
Contraception; 2008 Jul; 78(1):36-41. PubMed ID: 18555816
[TBL] [Abstract][Full Text] [Related]
27. The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women--effects on bleeding patterns, ovarian function and genital shedding of HIV.
Heikinheimo O; Lehtovirta P; Suni J; Paavonen J
Hum Reprod; 2006 Nov; 21(11):2857-61. PubMed ID: 16880227
[TBL] [Abstract][Full Text] [Related]
28. The levonorgestrel-releasing intrauterine system as an alternative to hysterectomy in peri-menopausal women.
Milsom I
Contraception; 2007 Jun; 75(6 Suppl):S152-4. PubMed ID: 17531608
[TBL] [Abstract][Full Text] [Related]
29. Migration of levonorgestrel IUS in a patient with complex medical problems: what should be done?
Soleymani Majd H; El Hamamy E; Chandrasekar R; Ismail L
Arch Gynecol Obstet; 2009 Mar; 279(3):385-6. PubMed ID: 18568357
[TBL] [Abstract][Full Text] [Related]
30. Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up.
Wildemeersch D; Janssens D; Pylyser K; De Wever N; Verbeeck G; Dhont M; Tjalma W
Maturitas; 2007 Jun; 57(2):210-3. PubMed ID: 17270370
[TBL] [Abstract][Full Text] [Related]
31. Intrauterine devices and adolescents.
Gold MA; Johnson LM
Curr Opin Obstet Gynecol; 2008 Oct; 20(5):464-9. PubMed ID: 18797269
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness analysis of levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
Brown PM; Farquhar CM; Lethaby A; Sadler LC; Johnson NP
BJOG; 2006 Jul; 113(7):797-803. PubMed ID: 16827763
[TBL] [Abstract][Full Text] [Related]
33. Treatment of menorrhagia with an LNG-IUS.
Pakarinen P; Luukkainen T
Contraception; 2007 Jun; 75(6 Suppl):S118-22. PubMed ID: 17531601
[TBL] [Abstract][Full Text] [Related]
34. Two cases of abortion and premature birth after removal of a levonorgestrel-releasing intrauterine system.
Rollnik JD; Lück HJ; Giersig C
Eur J Contracept Reprod Health Care; 2002 Dec; 7(4):244-6. PubMed ID: 12648298
[TBL] [Abstract][Full Text] [Related]
35. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial.
Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Kujansuu E; Tuppurainen M; Yliskoski M; Vuorma S; Paavonen J
BJOG; 2007 May; 114(5):563-8. PubMed ID: 17439564
[TBL] [Abstract][Full Text] [Related]
36. The levonorgestrel intrauterine system (Mirena) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction.
Lete I; Obispo C; Izaguirre F; Orte T; Rivero B; Cornellana MJ; Bermejo I;
Eur J Contracept Reprod Health Care; 2008 Sep; 13(3):231-7. PubMed ID: 18609346
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging.
Bragheto AM; Caserta N; Bahamondes L; Petta CA
Contraception; 2007 Sep; 76(3):195-9. PubMed ID: 17707716
[TBL] [Abstract][Full Text] [Related]
38. Spontaneous breakage and expulsion of a stem fragment of levonorgestrel intrauterine system (Mirena) following duplicate insertion.
Jindal S; Sharma SS; Ikomi A
Arch Gynecol Obstet; 2009 Jan; 279(1):95-7. PubMed ID: 18949478
[TBL] [Abstract][Full Text] [Related]
39. [Clinical study of levonorgestrel-releasing intrauterine system for adenomyosis].
He SM; Zhang YD
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1794-6. PubMed ID: 17259122
[TBL] [Abstract][Full Text] [Related]
40. Management of levonorgestrel-releasing intrauterine system (LNG-IUS) uterine perforation.
Margarit LM; Griffiths AN; Vine SJ
J Obstet Gynaecol; 2004 Aug; 24(5):586-7. PubMed ID: 15369954
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
